Weight Watchers Expands UK Partnership with CheqUp, Integrating GLP-1 Support
WW has more than doubled off its 52-week low of $8.365.
Summary
WW International has expanded its partnership with CheqUp in the UK, providing CheqUp members with access to the WW app and its GLP-1 companion program. This move reinforces WW's strategic shift towards integrating GLP-1 medication support, following the recent launch of its Med+ program. The company has faced significant revenue and subscriber declines, as reported in its Q1 2026 earnings, and an activist investor recently disclosed a stake. This partnership expansion is a positive step to drive subscriber growth and revenue in a key market by leveraging its updated offerings.
At the time of this announcement, WW was trading at $18.96 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $189.6M. The 52-week trading range was $8.37 to $46.95. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.